RAZADYNE (Janssen Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the RAZADYNE drug offered from Janssen Pharmaceuticals, Inc.. This Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Janssen Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | galantamine hydrobromide |
| SUBSTANCE NAME: | GALANTAMINE HYDROBROMIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2004-12-24 |
| END MARKETING DATE: | 0000-00-00 |
RAZADYNE HUMAN PRESCRIPTION DRUG Details:
| Item Description | RAZADYNE from Janssen Pharmaceuticals, Inc. |
| LABELER NAME: | Janssen Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 8(mg/1) |
| START MARKETING DATE: | 2004-12-24 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 50458-387_3236b68d-e757-4f5e-bbb7-aed95ebc0d3b |
| PRODUCT NDC: | 50458-387 |
| APPLICATION NUMBER: | NDA021615 |
Other GALANTAMINE HYDROBROMIDE Pharmaceutical Manufacturers / Labelers:
